A Win For China SXT Pharmaceuticals, Inc.
Mon, Feb 28, 2022 at 05:30 PM
China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ) jumped higher at $0.22, representing a gain of 45.3%. From Mon, Feb 14, 2022, the stock recorded 37.50% Up Days and 33.33% Green Days
The stock spiked on Fri, Jan 14, 2022 at $0.79 with a volume of 23M+.
About China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ)
China SXT Pharmaceuticals Inc is engaged in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces(TCMP). The company sells Advanced TCMP, Fine TCMP, and Regular TCMP. Generating a majority of its revenue from the Advanced TCMP. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
Top 10 Gainers:
- Mullen Automotive Inc. (MULN:NASDAQ), 145.64%
- NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 68.83%
- Document Security Systems, Inc. (DSS:NYSEMKT), 47.24%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 45.33%
- Renewable Energy Group, Inc. (REGI:NASDAQ), 40.38%
- IntriCon Corporation (IIN:NASDAQ), 37.37%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 35.96%
- Everbridge, Inc. (EVBG:NASDAQ), 29.11%
- First Horizon National Corporation (FHN:NYSE), 28.66%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 27.91%